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Highlights  
 Hysterectomy prevalence in Scotland has decreased by 23% between 1996 to 2015. 
 Uterine cancer incidence increased by 20% after adjusting for hysterectomies. 
 Annual percentage change in uterine cancer incidence in Scotland remained stable.  
 
Abstract 
Aim: Hysterectomy prevalence is decreasing worldwide. It is not clear if changes in the population at 
risk (women with intact uteruses) have contributed to an increased uterine cancer incidence. This 
study aims to assess the effect of changing trends in hysterectomy prevalence on uterine cancer 
incidence in Scotland. 
Methods: The population of women aged 25 years or older with intact uteri was estimated using 
estimated hysterectomy prevalence in 1995 and the number of procedures performed in Scotland 
(1996 – 2015). Age-standardised uterine cancer incidence was estimated using uncorrected (total) or 
corrected (adjusted for hysterectomy prevalence) populations as denominators and the number of 
incident cancers as numerators. Annual percentage change in uterine cancer was estimated.  
Results: Hysterectomy prevalence fell from 13% to 10% between 1996-2000 and 2011-2015, with 
the most marked decline, from 20% to 6%, in the 50-54 year age group.  Age-standardised incidence 
of uterine cancer increased after correction for hysterectomy prevalence by 20-22%. Annual 
percentage change in incidence of uterine cancer remained stable through the study period and was 
2.2 (95% CI 1.8 -2.7) % and 2.1 (95% CI1.7- 2.6) %, for uncorrected and corrected estimates, 
respectively.  
Conclusion:  Uterine cancer incidence in Scotland corrected for hysterectomy prevalence is higher 
than estimates using a total female population denominator. The annual percentage increase in 
uterine cancer incidence was stable in both uncorrected and corrected populations despite declining 
hysterectomy prevalence. The rise in uterine cancer incidence, thus, may be driven by other factors 
including an ageing population, changing reproductive choices and obesity.  
 
 
 
 
 
Introduction 
Uterine cancer or more specifically, corpus uteri cancer is the most common gynaecological cancer 
and the fourth most common cancer affecting women in the United Kingdom  [1]. In the past ten 
years, the incidence of uterine cancer in Scotland has increased by 32%, representing the greatest 
relative increase among all cancer types [2]. Similar trends have been reported in other developed 
countries. In the United States of America, uterine cancer is set to become the third most common 
female malignancy, surpassing lung and colorectal cancer [3, 4]. This increase in incidence is 
attributed to low grade endometrioid or type 1 cancers, thought to be driven by excess oestrogen 
and insulin associated with obesity [5]. Several authors, however, have highlighted that the changing 
patterns in hysterectomy could play an important part in influencing time trends in uterine cancer 
[6, 7]. In Scotland, the numbers of hysterectomies performed for benign conditions have more than 
halved since the mid-1990s [7], leaving a larger population of women at risk of developing uterine 
cancer. Similar patterns are seen in England and Wales [8].  
Inclusion of women who have had a hysterectomy in the population denominator leads to under-
estimation of incidence and risk of uterine cancer [9-11]. A lack of information regarding 
hysterectomy prevalence means that the total population of women is commonly used as the 
denominator in estimates of uterine cancer incidence. Thus, the true incidence of uterine cancer and 
accurate data on time trends are not known. We have tested the hypothesis that correcting for 
changing trends in hysterectomy prevalence will influence recent time trends in uterine cancer 
incidence.  
 Materials and Methods 
Data source 
Mid-year population data in five year age groups for 1996-2015 were provided by the National 
Records of Scotland [12]. As a consequence of imprecise coding, epidemiological studies tend to use 
uterine cancer [i.e. malignant neoplasm of corpus uteri (C54) and malignant neoplasm of uterus, 
part unspecified (C55), a majority of which arise from the endometrium] as the outcome of interest. 
Uterine cancer cases were identified by ICD-10  (tenth revision of International Classification of 
Diseases and Related Health Problems) codes of C54-55 and were obtained by year of diagnosis 
(1996-2015) and five-year age groups from Information Services Division (ISD) Scotland [2]. The 
study period was chosen to reflect the recent reduction in numbers of hysterectomies and to include 
the most recent data on cancer incidence.  
As in many countries, data on the prevalence of hysterectomy in Scotland are not available. 
Estimates of hysterectomy prevalence were generated using the assumption that the prevalence in 
1995 was similar to that estimated in England and Wales [6]. The number of hysterectomies carried 
out in Scotland between 1996 and 2015 by age group and calendar year was obtained from ISD 
[corresponding to the Office of Population Censuses and Surveys (OPCS-4) codes for hysterectomy 
Q07.2, Q07.4, Q07.5, Q08.2 and R25.1]. These data were derived from information regarding 
inpatient and day cases from publically funded hospitals in the Scottish Morbidity Records database, 
which corresponds to the Hospital Episode Statistics databases in England and Wales. A national 
linked database of general hospital discharge records, cancer registrations and mortality records has 
been established in Scotland by probability matching since 1981, while cancer registration data are 
recorded and available from 1958 onwards[13, 14]. More recently, widespread use of the 
Community Health Index (CHI), a unique national identifying number has strengthened the reliability 
of this data, with false positive and false negative linkages maintained below 1%[15]. 
Statistical Methods 
Estimation of hysterectomy prevalence and population at-risk 
The estimation of hysterectomy prevalence for each of the five year periods and the subsequent 
estimation of the female population at-risk of uterine cancer were performed using the method 
described by Lyon and Gardner [9]. The number of Scottish women who had a hysterectomy prior to 
1996 by five year age groups between 25 and 85+ years was estimated by multiplying the number of 
women in Scotland derived from mid-year population estimates by the hysterectomy prevalence 
estimated for England and Wales in the same age group. The lower age limit  of 24 years was chosen 
to match estimates for England and Wales [6]. The number of women who subsequently had a 
hysterectomy by calendar year and age group was: 
1. divided by the total female population to provide estimates of hysterectomy prevalence 
2. subtracted from the number of women in the original cohort to provide estimates of the 
population with an intact uterus and are therefore at risk of uterine cancer.  
The proportions of women who had an intact uterus was estimated by dividing the number of 
women estimated to have an intact uterus by the whole population of women in the cohort in each 
five year strata of age and calendar period.  These proportions were used as correction factors and 
were multiplied by the mid-year population estimates for each age group and calendar year for 
women aged 25 years or olderin Scotland between 1997 and 2015 to obtain estimates of the female 
population at risk of uterine cancer. The latter step enabled changes in population size and 
distribution from the original 1996 cohort to be taken into account. 
Estimation of uncorrected and corrected incidences of uterine cancer and analysis of trends 
The incidence of uterine cancer was estimated for each age group and five year period. The number 
of cases of uterine cancer (Supplementary Table 2) formed the numerator for estimates of incidence 
and the total female population was the denominator for uncorrected estimates while the female 
population at risk was the denominator for corrected estimates of uterine cancer incidence. Direct-
standardisation using the European Standard Population 2013 [16] was used to generate age-
standardised estimates.  
The annual percentage change (APC) was estimated using JoinPoint software using the Akaike 
Information Criterion model. A minimum of zero joinpoints and a maximum of three joinpoints were 
allowed in the regression to identify linearity of time trends [17]. Mid-year age-standardised 
incidence of uterine cancer was used as the dependent variable, and calendar year as the 
independent variable in the regression models. The analysis was carried out using Rx64 3.3.3 and 
JoinPoint regression software (Desktop version 4.5.0.1). Methodological detail are included in 
Supplementary Material. 
Results 
Hysterectomy prevalence among all women aged 25 years or older in Scotland was estimated to be 
13% in 1996-2000 and 10% in 2011-2015 (Table 1). The proportions of women who had a 
hysterectomy decreased over time in younger women (for example from 20% to 6% for women of 
50-54 years of age, but increased in the women over 64  years of age; for example from 18% to 20% 
in women of 70-74 years of age between 1996-2000 and 2011-2015. The numbers of incident 
uterine cancers increased by 40%, from 2,432 cases in 1996-2000 to 3,973 cases in 2011-2015.  
Corrected and uncorrected incidence of uterine cancer 
Before correction, uterine cancer incidence (95% confidence intervals) per 100,000 women 
increased from 20.5 (19.7 to 21.3) in 1996-2000 to 28.4 (27.5 to 29.3) in 2011-2015. Following 
correction for hysterectomy prevalence, the age-standardised incidence of uterine cancer was 20-
22% higher over all time periods (Table 1 & Figure 1).  
The uncorrected increase in incidence between the first and last five year calendar period was 39%. 
After correction, the incidence of uterine cancer increased by 36%; from 25/100,000 (95%CI 24-26) 
women in 1996-2000 to 34/100,000 (95%CI 33-35) in 2011-2015 (Table 1). This discrepancy between 
uncorrected and corrected time trends reflects the decrease in prevalence of hysterectomy over 
time and a smaller difference between the whole female population and the female population at 
risk in the latter time periods. The peak age of uterine cancer incidence increased; from 60-64 years 
in 1996-2001 to 70-74 years in 2011-2015 (Figure 1).   
The joinpoint regression analysis did not identify any joinpoints, demonstrating that the annual rate 
of increase in uterine cancer incidence was linear throughout the study period. Figure 2 shows time 
trends in uterine cancer incidence from 1996 to 2015 before and after correction for hysterectomy 
prevalence. The annual percentage changes were 2.2% (95% CI 1.8 to 2.7) in uncorrected incidence 
and were slightly lower at 2.1% (95% CI 1.7 to 2.6) in corrected incidences. 
 
Discussion 
Hysterectomy prevalence decreased between 1996 and 2015 in Scotland, resulting in a higher 
proportion of women at risk of uterine cancer.  Correcting female population estimates for 
hysterectomy prevalence revealed an increase in estimated uterine cancer incidence by 22% 
between 1996 -2010 and by 20% between 2011-2015.  However, correcting for changing 
hysterectomy prevalence had little effect on time trends of uterine cancer estimates. 
Patterns of changing prevalence of hysterectomy varied with age.  Estimated hysterectomy 
prevalence between 1996 and 2015 decreased among women < 65 years, while increasing in older 
women, as a consequence of the age-period-cohort effect [18, 19]. Hysterectomy prevalence was 
particularly high in the cohort born in 1942-1950 and likely to have undergone a hysterectomy 
between 1982-2000; hysterectomies were commonly performed among women aged 40 to 50 years 
[6]. 
 Approximately 60% of British women with heavy menstrual bleeding referred to a gynaecologist 
underwent a hysterectomy prior to 1991 [20]. Subsequent introduction of effective non-surgical 
therapies including endometrial ablation and the levonorgestrel-releasing intrauterine coil resulted 
in a reduction in hysterectomies. The annual number of hysterectomies performed in England fell by 
two-thirds between 1995 and 2005 [8]. 
The hysterectomy prevalence estimates obtained in Scotland were lower than those reported by 
previous UK studies in earlier time periods [6] and half the prevalence reported by a recent German 
study [21]. These differences could be due to time trends described above and one or both of lower 
starting hysterectomy prevalence or a sharper decrease in hysterectomy incidence over time in 
Scotland.  
The estimates of uncorrected and corrected uterine cancer incidence obtained were higher than 
those estimated for England and Wales for 1971-1992. Redburn and Murphy report a corrected 
uterine cancer incidence of 16/100,000 women in England and Wales in 1992 [6], compared with 
21/100,000 women in our study in 1996-2000. This increase is in keeping with reported trends in UK 
uterine cancer incidence. The effects of correcting for hysterectomy on uterine cancer incidence 
appear to have remained constant at 17-22% over the time period covered by the two studies.  This 
finding suggests that factors other than changing hysterectomy prevalence (e.g  rising trends in 
obesity and diabetes, global changes in reproductive choices i.e. nulliparity [22] ) are contributing to 
the increasing incidence and risk of uterine cancer over time. In Finnish populations, correcting for 
hysterectomy resulted in a 29% increase in the incidence of uterine cancer. In Finland, uncorrected 
uterine cancer rates showed a plateau in the 1980s, not seen in corrected rates, which was 
explained by the increasing prevalence of hysterectomy [23]. These are converse to our findings in 
Scotland where time trends in uncorrected and corrected incidence were similar, thus re-iterating 
the possible causative role of obesity in increasing uterine cancer incidence. 
Our findings differ from American studies reporting corrected incidence rates of uterine cancer of 
57-66/100,000 women, almost double the reported rate in Scotland [24]. The increase following 
correction for hysterectomy prevalence ranged from 65-73% in white, non-Hispanic women, and up 
to 93% in black non-Hispanic women [25, 26]. This difference emphasises the potential significant 
underestimation of uterine cancer in a population where hysterectomies are commonly performed.  
This study is the first to estimate uterine cancer incidence corrected for hysterectomy prevalence in 
Scotland, where the rates of hysterectomy have more than halved in the last 15 years[7]. A strength 
of this study is the robust national population-based data capture, coding and linkage of uterine 
cancer cases and hysterectomy procedures. Hospital admissions and surgical procedures, including 
hysterectomy are recorded for all patients admitted to Scottish National Health Service (NHS) 
hospitals. The quality of cancer registration data in Scotland is believed to be comparatively 
high[27]. This is based on routinely available indicators and studies of completeness of case 
ascertainment[28] and data reliability[29].  Recent quality assurance data suggests that in hospital 
discharge records coding of clinical conditions and procedures is maintained at an accuracy of 89-
94%[30]. Uterine cancer was used as the main outcome, which incorporates both malignant 
neoplasm of the corpus uteri (C54) and malignant neoplasm of uterus part unspecified (C55), as a 
large proportion of cancers of the uterus are described as “not specified”. Neoplasm of the corpus 
uteri is a more precise code for uterine or endometrial cancer, because the malignant neoplasm of 
the uterus, part unspecified code may incorporate cancer of the cervix. However, in a sensitivity 
analysis limited to cases coded as corpus uteri (C54), the percentage increase from uncorrected to 
corrected incidence was identical at 20-22%.  
A limitation of this study in the estimation of hysterectomy prevalence is the use of the Lyon and 
Gardner approach [9] which assumes a static population and  that hysterectomy prevalence at the 
start of 1996 would be similar in Scotland to that in England and Wales.  The correction factors 
derived were obtained using an index population originating from the population in the first year of 
interest from which women who have had hysterectomies in subsequent years are cumulatively 
excluded. Unfortunately we were unable to find a source of data that would have allowed us to 
validate our estimates of hysterectomy prevalence.  This approach does not permit a completely 
accurate estimate of time at risk because all estimates were based on calendar years rather than 
using exact dates.  Women who have a hysterectomy for uterine cancer are included in the 
numerator in the year in which the cancer was recorded and are excluded from the denominator 
(and numerator) for the subsequent year.  Joinpoint regression aims to identify time points where 
trends change. Although  this analysis only applies to annual percentage change and prevalence 
change was not carried out from one period to the next, prevalence change had been accounted for 
during the estimation of incidence. Finally, ISD data are collected from publically funded NHS 
hospitals and information on the anecdotally small number of hysterectomies carried out privately 
were not available.  
This study has shown that the incidence of uterine cancer is significantly underestimated when 
hysterectomy prevalence is not taken into account. However, even after adjusting for hysterectomy 
prevalence, the incidence of uterine cancer has increased by 36% between 1996 and 2015. Thus, the 
increase in uterine cancer incidence must have other causative factors. Ageing of the population 
contributes to increasing numbers of incident cases over time but does not influence age-
standardised rates.  As hysterectomy prevalence decreased over time the relative difference 
between uncorrected and corrected estimates of incidence declined slightly but still remained 
around 20%. While we anticipated that correcting for declining hysterectomy prevalence would 
result in a larger female population at risk and thus a greater annual percentage increase in 
incidence, the annual percentage change remained stable over the study period. Consequently, 
while uterine-sparing therapies and a decrease in hysterectomy prevalence have contributed to the 
recent increase in uterine cancer incidence in Finland, this is not the case in Scotland.  It is instead 
likely that the obesity epidemic is a key driver in the upsurge of uterine cancer cases. 
Another factor to consider is that the recent decline in hysterectomies has not yet affected the age 
group where uterine cancers occur. Women born after 1955, who have undergone the lowest 
number of hysterectomies are approaching the peak age (60-69) for first diagnosis of uterine cancer. 
Thus the impact of declining hysterectomy prevalence may be impending. A further explanation for 
our findings is that morbidly obese women who are at the highest risk of uterine cancer, are the 
least likely to be offered a hysterectomy for benign causes, because of increased surgical morbidity. 
We have demonstrated the importance of using a corrected female population denominator, by 
excluding women who have had a hysterectomy, in providing more accurate estimates of uterine 
cancer incidence in Scotland. Ongoing research is required to establish the longer-term 
consequences of the reducing prevalence of hysterectomy, particularly as the cohort of women 
among whom it will have the most impact reaches the age at which uterine cancer incidence is 
highest.  Identifying effective approaches to the prevention and management of obesity remains an 
important challenge to thwart further increases in uterine cancer incidence. 
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 Figure Captions 
Figure 1. Age-specific uterine cancer incidence in Scotland for 1996-2001 and 2011-2015, 
uncorrected and corrected for prevalence of  hysterectomy. 
Figure 2. Annual age-standardized incidence of uterine cancer before and after correcting for 
hysterectomy prevalence for the study period ( 1996-2015.) 
 Tables 
Table 1: Estimated proportions (of women aged 25 years or older in Scotland who had a 
hysterectomy by five-year age-group from 25-29 to 85+and five year periods between 1996 and 
2015.  
 
 
 
 
 
Age Group Percentage prevalence of hysterectomies in females in Scotland 
 1996-2000 2001-2005 2006-2010 2011-2015 
25-29 0.3 0.1 0 0 
30-34 1.6 0.5 0.2 0.1 
35-39 5 2 0.7 0.3 
40-44 10.4 5.4 2.4 1 
45-49 16.1 11 6 2.7 
50-54 20.2 16.4 11.2 6.2 
55-59 20.3 20.4 16.6 11.4 
60-64 19.1 20.5 20.5 16.8 
65-69 18.2 19.2 20.6 20.7 
70-74  17.7 18.3 19.4 20.8 
75-79 17 17.8 18.4 19.5 
80-84 15.5 17.1 17.9 18.5 
85+ 13.2 15.5 17.1 17.9 
 Table 2: Age-standardised incidence of uterine cancer per 100,000 female population for each five-
year period between 1996 and 2015 in Scotland before and after adjusting for hysterectomy 
prevalence and absolute and relative increases after correction. 
Five Year 
Period 
Uncorrected 
incidence/100,000 
(95%CI) 
Corrected 
incidence/100,000 
(95%CI) 
Absolute 
change 
(increase) after 
correction/    
100,000 
Percentage 
increase 
after 
correction 
(%) 
1996-2000 20.5 (19.7 – 21.3) 25.0 (24.0 – 26.0) 4.5 22 
2001-2005 22.6 (21.8 – 23.5) 27.6 (26.6 – 28.6) 5.0 22 
2006-2010 25.0 (24.2 – 25.9) 30.4 (29.4 – 31.5) 5.4 22 
2011-2015 28.4 (27.5 – 29.3) 34.1 (33.0 – 35.2) 5.7 20 
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Supplementary Information : Estimating prevalence of hysterectomy in Scotland (1996-2015) 
This file describes the method used to derive estimates of hysterectomy prevalence in Scotland 
during the study period 1996-2015. The approach adopted was essentially that used by Lyon & 
Gardner 9, and was based on the following principles:- 
 The study period would be divided into periods of five calendar years (1996-2000; 2001-
2005; 2006-2010; and 2011-2015). 
 Within each time period, age-specific prevalence of hysterectomy would be estimated for 
five-year age intervals (0-4, 5-9, 10-14, 15-19... ...80-84, with a final open interval 85+); 
however, zero prevalence would be assumed for all ages below 25 years. 
 The starting prevalence values required to ‘initialise’ the method of Lyon & Gardner would 
be the five-year age-specific averages for England and Wales during the period 1991-1995 as 
reported by Redburn & Murphy (Table 1 in6). 
Reflecting these principles, estimation proceeded as now described.   
First, all-Scotland female population totals for 1996 (the earliest year of the study period) were 
obtained from National Records of Scotland 12.Then, a cohort model population was created by 
‘aging’ these values following the method of Lyon & Gardner.  Adopting the notation of ref. 9, the 
period- and age-specific population is generated as follows:- 
for j = 1: Pi1 = 1996 female population of Scotland 
for j > 1: Pij = Pi-1, j-1,  
where i represents the grouped age (0-4, 5-9, 10-14, 15-19... ...80-84, 85+) and j denotes the five-
year time period (j = 1: 1996-2000; j = 2: 2001-2005; j = 3: 2006-2010; j = 4: 2011-2015).  An 
illustration of the aging process is given in Supplementary Table 1.  Note that age groups earlier than 
25 years are necessarily involved in the process (to avoid age groups of interest being ‘lost’ as time 
advances) even though - as previously stated - an assumption of zero hysterectomy prevalence at 
ages <25 was made.  Under this scheme, the size of the population is assumed to remain static (i.e. 
births, deaths and migrations are deemed not to occur).  This is clearly a highly artificial assumption, 
and merits highlighting as a limitation of the method.   
Next, the model population was adjusted by removing the numbers of women deemed to have had 
a hysterectomy.  Continuing with the notation of Lyon & Gardner, the population in each age group / 
time period stratum (the quantity Pij introduced above) was modified as follows:- 
for j = 1: P’i1 = Pi1(1 - Hi1)   
for j > 1: P’ij = P’i-1, j-1 - PijHij, 
where Hi1 represents the prevalence of hysterectomy in the ith age group for the period 1991-1995 
as reported by Redburn & Murphy (Table 1 in ref. 6) and the Hij (j > 1) represent the observed 
hysterectomy incidence rate (in the actual - not model - population of interest) for the preceding 
five-year time period.  Some illustration of the process may be helpful.   
Supplementary Table 2 repeats the ‘1996-2000’ column of Supplementary Table 1, but with 
additional elements in each cell as follows.  The central element represents the prevalence of 
hysterectomy (from Redburn & Murphy, re-expressed as a proportion e.g. ‘1.6%’ is presented as 
0.016).  This is the quantity Hi1, in the notation of Lyon & Gardner.  The lowermost cell entry gives 
the adjusted population P’i1.  Thus, for the age group 25-29 the adjusted population P’i1 is given by 
198 148 * (1 - 0.003) = 198 148 * 0.997 = 197 554 (rounded to nearest integer).   
Similarly, the adjusted population P’i1 for age group 30-34 is calculated as 
208 113  * (1 - 0.016) = 208 113 * 0.984 = 204 783. 
For the remaining time periods (2001-2005 and later), the calculation of P’ij is more complex, 
because the quantity Hij now represents the observed incidence of hysterectomy (described by Lyon 
& Gardner as ‘the operative hysterectomy rate’) in the preceding five-year time period j-1.  A 
detailed example calculation for P’ij is now provided.  For the age-group 30-34 in the time period 
2001-2005, the model population total Pij is 198,148; the adjusted model population total in the 
previous age group / time period P’i-1, j-1 is 197 554 (see Table 2); and the operative hysterectomy 
rate Hij is approximated by calculating the average of the observed hysterectomy incidence rates for 
ages 30-34 over the five individual years of the preceding time period (1996-2000). It merits 
highlighting that the notation of Lyon & Gardner is arguably slightly misleading here.  The quantity Hij 
for j > 1 is defined as ‘the operative hysterectomy rate for the preceding five-year period’ [ref. (9) p. 
440; emphasis added], so it might be more correct to identify this quantity as Hij-1.  However, the 
original notation is retained in the interests of consistency.   
The numbers of hysterectomies performed at ages 30-34 and the corresponding year-specific total 
Scottish female populations, together with the hysterectomy incidence rates during 1996-2000, are  
1996: 461 / 208 113 (incidence rate = 0.00222) 
1997: 405 / 208 070 (0.01946) 
1998: 429 / 206 727 (0.00208) 
1999: 369 / 203 848 (0.00181) 
2000: 250 / 199 590 (0.00125). 
The average of the five rates is 0.00186, and this is treated as the five-year operative hysterectomy 
rate at ages 30-34 for the period 1996-2000.  After Lyon & Gardner, the adjusted population is 
calculated as P’ij = P’i-1, j-1 - Pij Hij; substituting the values derived as just described yields  
P’ij = 197 554 - (198 148 * 0.001865) = 197,185 (rounded to nearest integer).  This is the adjusted (i.e. 
hysterectomy-free) model population aged 30-34 in the five-year time period 2001-2005. 
The final stage in the process of Lyon & Gardner involves calculating the ‘correction factor’  
 
fij = P’ij / Pij, 
 
representing the adjustment which is applied to the actual (observed) population to arrive at the 
adjusted (hysterectomy-free) population, intended for use here as the denominator in calculating 
the incidence of endometrial cancer.  Continuing with the example used above, the correction factor 
fij for the age group 30-34 during the period 2001-2005 is (197 185 / 198 148) = 0.995139.  The 
actual Scottish female population aged 30-34 during 2001-2005 is approximated as the sum of the 
five year-specific population totals 
 
2001: 197 055 women aged 30-34 
2002: 192 648 
2003: 185 991 
2004: 178 776 
2005: 172 849 
TOTAL: 927 319 
 
Applying the correction factor, the adjusted (hysterectomy-free) female population aged 30-34 
during the time period is estimated as 0.995139 * 927 319 = 922 812 (rounded to nearest integer). 3)  
Supplementary Table 3 shows the correction factors fij for the age range of interest (25 upwards) for 
each of the four time periods.  This may be directly compared with Table 2 in Lyon & Gardner.  Note 
that the correction factors may also be interpreted as prevalence rates for hysterectomy via the 
simple relation  
 prevalence = 1 - fij. 
Adjusted population totals (i.e. the observed population in each age group / time period multiplied 
by the correction factors of Table 3) were used as denominators in the calculation of endometrial 
cancer rates for this study; they represent the estimated numbers of women at risk i.e. those 
considered hysterectomy-free.  
Supplementary Table Legends 
Supplementary Table 1. Observed (column ‘1996’) and aged (remaining columns) population totals 
(women in Scotland).  Note that cell contents propagate diagonally from upper left to lower right as 
time progresses.  Italicised cells in leftmost column mark age groups which are not of direct interest 
i.e. those for which prevalence estimates will not be derived (these rows are intentionally left blank). 
Supplementary Table 2. Illustration of calculating adjusted population P’i1 for earliest time period 
(see text for details). 
Supplementary Table 3: Correction factors (proportion of actual population assumed not to have 
undergone hysterectomy) in specified age group / time period.  The quantity (1 - cell content) is 
interpreted as the prevalence of hysterectomy. 
 Supplementary Table 1 
 
 Time Period 
Age group 1996-2000 2001-2005 2006-2010 2011-2015 
10-14     
15-19     
20-24     
25-29 198 148 170 987 153 140 156 660 
30-34 208 113 198 148 170 987 153 140 
35-39 194 993 208 113 198 148 170 987 
40-44 171 653 194 993 208 113 198 148 
45-49 178 707 171 653 194 993 208 113 
etc. ... ... ... ... 
 
 Supplementary Table 2  
age group 1996-2000 
10-14  
15-19  
20-24  
25-29 198 148 
0.003 
197 554 
30-34 208  113 
0.016 
204 783 
35-39 194 993 
0.050 
185 243 
40-44 171 653 
0.104 
153 801 
45-49 178 707 
0.161 
149 935 
etc. ... 
 
 Supplementary Table 3 
Age group 1996-2000 2001-2005 2006-2010 2011-2015 
25-29 0.997 0.999 1.000 1.000 
30-34 0.984 0.995 0.998 0.999 
35-39 0.950 0.980 0.993 0.997 
40-44 0.896 0.944 0.976 0.990 
45-49 0.839 0.890 0.940 0.973 
50-54 0.798 0.836 0.888 0.938 
55-59 0.797 0.796 0.834 0.886 
60-64 0.809 0.795 0.795 0.832 
65-69 0.818 0.808 0.794 0.793 
70-74 0.823 0.817 0.806 0.792 
75-79 0.830 0.822 0.816 0.805 
80-84 0.845 0.829 0.821 0.815 
85+ 0.868 0.845 0.829 0.821 
 
 
 
